GlassScriptPhysician profile
Larry Shea Hailey
NPI 1225232895
$9,956.63
in general payments reported to CMS, 2019-2025
30 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,255 · 2020: $960 · 2021: $1,209 · 2022: $887 · 2023: $3,623 · 2024: $690 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,598 · Food and Beverage: $2,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,597.55 |
| Food and Beverage | $2,048.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,041.00 | 2019-2024 | Impella |
| Boston Scientific Corporation | $1,854.40 | 2020-2023 | Versacross Access Solution |
| Medtronic, INC. | $1,418.34 | 2021-2023 | Micra |
| Novartis Pharmaceuticals Corporation | $1,398.82 | 2019-2025 | |
| Abbott Laboratories | $1,185.51 | 2019-2023 | Cardiomems |
| Merck Sharp & Dohme LLC | $339.92 | 2021-2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $279.36 | 2019-2023 | Farxiga |
| Pfizer INC. | $263.45 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $180.51 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $157.97 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $129.90 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $92.32 | 2019-2023 | Repatha |
| Philips North America LLC | $73.25 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $64.99 | 2019-2024 | Evkeeza |
| Sanofi-Aventis U.S. LLC | $56.82 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $49.94 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astellas Pharma US INC | $46.02 | 2019-2021 | |
| Esperion Therapeutics, INC. | $45.42 | 2021-2025 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $40.85 | 2024 | |
| Atricure, INC. | $35.97 | 2023 | |
| W. L. Gore & Associates, INC. | $30.88 | 2024 | Gore Tag Conformable Thoracic Stent Graft |
| Medtronic Vascular, INC. | $29.58 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $28.04 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.02 | 2025 | |
| Amarin Pharma, INC. | $19.04 | 2019 | |
| Cvrx, INC. | $18.53 | 2024 | Barostim Neo System |
| Itamar Medical INC | $14.89 | 2023 | Watchpatone |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.64 | 2023 | Jardiance |
| Novo Nordisk INC | $11.73 | 2022 | |
| Bardy Diagnostics, INC. | $7.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Hailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.